Analysts' Actions: BA, MCD, HES, NFLX, DAL

Global Payments (GPN) downgraded at Stifel from Buy to Hold,

HCA (HCA) downgraded at Auriga from Buy to Hold. $28 price target. Industry still faces macro headwinds.

Hess (HES) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $62 price target. Company has a very aggressive spending program in 2012.

Hologic (HOLX) downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.

Illumina (ILMN) upgraded at Baird to Outperform, Robert Baird said. $60 price target. Stock likely to trade above Roche's hostile bid.

Illinois Tool Works (ITW) upgraded at BofA/Merrill from Underperform to Buy, Bank of America/Merrill Lynch said. $64 price target. Company is cutting costs and deserves a higher price multiple.

Knight Transportation (KNX) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. Valuation call, based on a $20 price target.

Life Technologies (LIFE) upgraded at Leerink from Market Perform to Outperform, Leerink Swann said. Nextgen sequencing is an attractive growth area.

Netflix (NFLX) upgraded at Citigroup to Buy from Neutral, Citigroup said. $130 price target. Strong quarter and positive guidance.

OGE Energy (OGE) downgraded at Jefferies to Hold from Buy, Jefferies said. $58.50 price target. Lower assumed processing and gathering volumes at Enogex.

Progressive (PGR) downgraded at Goldman to Sell. $18 price target. Pricing trends are better in the commercial lines.

Sally Beauty (SBH) rated new Neutral at Goldman. $22 price target. Company has limited earnings upside potential.

Charles Schwab (SCHW) downgraded at JP Morgan to Neutral. Estimates also cut, given a lower net interest margin and a difficult sales environment.

St. Jude (STJ) upgraded at Canaccord from Hold to Buy. $50 price target. Guidance will likely prove to be conservative.

Thomson Reuters (TRI) downgraded at Goldman from Neutral to Sell. $25 price target. Company is leveraged to weaker financial services and European demand.

Trustmark (TRMK) downgraded at KBW to Underperform, Keefe, Bruyette & Woods said. Valuation call, based on a $21 price target. Estimates also cut.

Textron (TXT) upgraded at Earlybird to Buy, Earlybird Capital said. $30 price target. End-market demand is improving and the company has operating leverage.

« First ‹ Previous 1 2 3 4 Next › Last »